Intravitreal triamcinolone for refractory diabetic clinically significant macular oedema
Esculapio. 2011; 7 (3): 19-22
in English
| IMEMR
| ID: emr-195427
ABSTRACT
Objective:
to determine long term effects on final visual outcome, macular fluorescein leakage and intraocular pressure after intravitreal injection of triamcinolone for treating refractory diabetic clinically significant macular oedema [CSMO]
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Language:
English
Journal:
Esculapio
Year:
2011
Similar
MEDLINE
...
LILACS
LIS